Study details
Enrolling now
Accelerated TMS for Depression
Neuronetics
NCT IDNCT07147218ClinicalTrials.gov data as of Apr 2026
Target enrollment
50
Study length
about 2.4 years
Ages
15+
Locations
3 sites in NC, NY, WA
What this study is about
This trial is testing a new way to treat depression using Accelerated Transcranial Magnetic Stimulation (TMS). The goal is to see if this treatment can help people with Major Depressive Disorder (MDD) feel better.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Use TMS
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Change in MADRS score from baseline to post-treatment.
Secondary: Change in PHQ-9 from baseline to post-treatment.
Devices
therapeutic
Body systems
Psychiatry / Mental Health